This week TiGenix reported positive safety data for its stem cell therapy for rheumatoid arthritis. The news highlights the potential of regenerative medicine as Science|Business publishes a special report examining how Europe can build on its leading position in this fast-paced field of research
EU budget negotiations may be stalled, with possible consequences for future R&D funding. But at least one collaborative science project – the European Space Agency - has agreed its long-term funding
IEA Executive Director Maria van der Hoeven discusses how Energy efficiency and renewable energy technologies will play a vital role in the transition to a secure and sustainable energy future
Europe currently leads the world in therapeutic applications of regenerative medicine. It has seen companies spin out from universities and approved products reaching the market. Science|Business brought together experts to discuss how to build on these foundations
Interview with Professor David Zilberman, professor of agricultural and resource economics at the University of California, Berkeley and principal investigator at the UC Berkeley Energy Biosciences Institute
Research counters public criticism on ‘inefficiency.’ Risks of intermittent power have been overstated and projected wind power levels for 2020 do not require major system adaptation. Technology can provide solutions to tap greater amounts of wind power.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and the fortnightly R&D Express, tracking reforms and investments in central and eastern Europe.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.